Summit Therapeutics
SMMT
trading on NASDAQ
since 2015
$18.54
(Δ -29.26%)
-$7.67 since open
Summit Therapeutics is a biopharmaceutical company focused on advancing novel therapies for rare diseases, with a diverse pipeline of clinical-stage programs targeting conditions with significant unmet medical needs.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $21.20 | $21.63 | $18.01 | $19.04B | 19.85M |
| eps | p/e | p/s |
operating margin |
profit margin |
yield |
| -$0.09 | n/a | +Inf | 0% | -Inf% | 0% |